Intravac and Celonic Group have signed a research agreement to further design, develop, and produce a COVID-19 vaccine based on an immunogenic Spike (S) protein of SARS-CoV-2 combined with Intravacc’s prorietary Outer Membrane Vesicle (OMV) technology.   In March, Intravacc started working on the development of four candidate coronavirus vaccines based on three proprietary technologies: Vero cell, OMV and iBoost.   For this specific joint vaccine development, Intravacc combines its safe and immu...